Investigation of the function of the putative self-association site of Epstein-Barr virus (EBV) glycoprotein 42 (gp42)

Virology

Volumn 415, Issue 2, 2011, Pages 122-131

  Rowe, Cynthia L ^a   Matsuura, Hisae ^b,c   Jardetzky, Theodore S ^b   Longnecker, Richard ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Epstein Barr virus; Glycoprotein; Gp42

Indexed keywords

GLYCOPROTEIN GP 42; GLYCOPROTEIN H; GLYCOPROTEIN L; HLA ANTIGEN CLASS 2; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN;

ANIMAL CELL; ARTICLE; CELL FUSION; CELL SURFACE; COMPLEX FORMATION; CONTROLLED STUDY; DIMERIZATION; EPSTEIN BARR VIRUS; GEL FILTRATION; MEMBRANE BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN CLEAVAGE; PROTEIN FUNCTION; PROTEIN MULTIMERIZATION; VIRUS ENTRY;

ANIMALS; CELL LINE; EPSTEIN-BARR VIRUS INFECTIONS; GLYCOPROTEINS; HERPESVIRUS 4, HUMAN; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; PROTEIN BINDING; PROTEIN MULTIMERIZATION; VIRAL PROTEINS;

HUMAN HERPESVIRUS 4;

EID: 79957784847     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2011.04.003     Document Type: Article

References (38)

1. Bieging K.T., Swanson-Mungerson M., Amick A.C., Longnecker R. Epstein-Barr virus in Burkitt's lymphoma: a role for latent membrane protein 2A. Cell Cycle 2010, 9:901-908.
2. Borza C.M., Hutt-Fletcher L.M. Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus. Nat. Med. 2002, 8:594-599.
3. Carfi A., Willis S.H., Whitbeck J.C., Krummenacher C., Cohen G.H., Eisenberg R.J., Wiley D.C. Herpes simplex virus glycoprotein D bound to the human receptor HveA. Mol. Cell 2001, 8:169-179.
4. Chesnokova L.S., Nishimura S.L., Hutt-Fletcher L.M. Fusion of epithelial cells by Epstein-Barr virus proteins is triggered by binding of viral glycoproteins gHgL to integrins alphavbeta6 or alphavbeta8. Proc. Natl Acad. Sci. U. S. A. 2009, 106:20464-20469.
5. Fan Q., Longnecker R. The Ig-like v-type domain of paired Ig-like type 2 receptor alpha is critical for herpes simplex virus type 1-mediated membrane fusion. J. Virol. 2010, 84:8664-8672.
6. Fingeroth J.D., Weis J.J., Tedder T.F., Strominger J.L., Biro P.A., Fearon D.T. Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc. Natl Acad. Sci. U. S. A. 1984, 81:4510-4514.
7. Haan K.M., Kwok W.W., Longnecker R., Speck P. Epstein-Barr virus entry utilizing HLA-DP or HLA-DQ as a coreceptor. J. Virol. 2000, 74:2451-2454.
8. Handler C.G., Eisenberg R.J., Cohen G.H. Oligomeric structure of glycoproteins in herpes simplex virus type 1. J. Virol. 1996, 70:6067-6070.
9. Hennecke J., Wiley D.C. Structure of a complex of the human alpha/beta T cell receptor (TCR) HA1.7, influenza hemagglutinin peptide, and major histocompatibility complex class II molecule, HLA-DR4 (DRA*0101 and DRB1*0401): insight into TCR cross-restriction and alloreactivity. J. Exp. Med. 2002, 195:571-581.
10. Hennecke J., Carfi A., Wiley D.C. Structure of a covalently stabilized complex of a human alphabeta T-cell receptor, influenza HA peptide and MHC class II molecule, HLA-DR1. EMBO J. 2000, 19:5611-5624.
11. Jiang R., Gu X., Nathan C.O., Hutt-Fletcher L. Laser-capture microdissection of oropharyngeal epithelium indicates restriction of Epstein-Barr virus receptor/CD21 mRNA to tonsil epithelial cells. J. Oral Pathol. Med. 2008, 37:626-633.
12. Kirschner A.N., Omerovic J., Popov B., Longnecker R., Jardetzky T.S. Soluble Epstein-Barr virus glycoproteins gH, gL, and gp42 form a 1:1:1 stable complex that acts like soluble gp42 in B-cell fusion but not in epithelial cell fusion. J. Virol. 2006, 80:9444-9454.
13. Kirschner A.N., Lowrey A.S., Longnecker R., Jardetzky T.S. Binding-site interactions between Epstein-Barr virus fusion proteins gp42 and gH/gL reveal a peptide that inhibits both epithelial and B-cell membrane fusion. J. Virol. 2007, 81:9216-9229.
14. Kirschner A.N., Sorem J., Longnecker R., Jardetzky T.S. Structure of Epstein-Barr virus glycoprotein 42 suggests a mechanism for triggering receptor-activated virus entry. Structure 2009, 17:223-233.
15. Krummenacher C., Supekar V.M., Whitbeck J.C., Lazear E., Connolly S.A., Eisenberg R.J., Cohen G.H., Wiley D.C., Carfi A. Structure of unliganded HSV gD reveals a mechanism for receptor-mediated activation of virus entry. EMBO J. 2005, 24:4144-4153.
16. Li Q., Spriggs M.K., Kovats S., Turk S.M., Comeau M.R., Nepom B., Hutt-Fletcher L.M. Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes. J. Virol. 1997, 71:4657-4662.
17. Liu F., Marquardt G., Kirschner A.N., Longnecker R., Jardetzky T.S. Mapping the N-terminal residues of EBV gp42 that bind gH/gL using fluorescence polarization and cell-based fusion assays. J. Virol. 2010, 84:10375-10385.
18. Longnecker R. Molecular biology of Epstein-Barr virus. Human Tumor Viruses 1998, 133-174. American Society for Virology, Washington, D.C. D.J. McCance (Ed.).
19. McShane M.P., Mullen M.M., Haan K.M., Jardetzky T.S., Longnecker R. Mutational analysis of the HLA class II interaction with Epstein-Barr virus glycoprotein 42. J. Virol. 2003, 77:7655-7662.
20. Mullen M.M., Haan K.M., Longnecker R., Jardetzky T.S. Structure of the Epstein-Barr virus gp42 protein bound to the MHC class II receptor HLA-DR1. Mol. Cell 2002, 9:375-385.
21. Murthy V.L., Stern L.J. The class II MHC protein HLA-DR1 in complex with an endogenous peptide: implications for the structural basis of the specificity of peptide binding. Structure 1997, 5:1385-1396.
22. Nemerow G.R., Mold C., Schwend V.K., Tollefson V., Cooper N.R. Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV/C3d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3d. J. Virol. 1987, 61:1416-1420.
23. Pulford D.J., Lowrey P., Morgan A.J. Co-expression of the Epstein-Barr virus BXLF2 and BKRF2 genes with a recombinant baculovirus produces gp85 on the cell surface with antigenic similarity to the native protein. J. Gen. Virol. 1995, 76(Pt 12):3145-3152.
24. Reinherz E.L., Tan K., Tang L., Kern P., Liu J., Xiong Y., Hussey R.E., Smolyar A., Hare B., Zhang R., Joachimiak A., Chang H.C., Wagner G., Wang J. The crystal structure of a T cell receptor in complex with peptide and MHC class II. Science 1999, 286:1913-1921.
25. Ressing M.E., van Leeuwen D., Verreck F.A., Gomez R., Heemskerk B., Toebes M., Mullen M.M., Jardetzky T.S., Longnecker R., Schilham M.W., Ottenhoff T.H., Neefjes J., Schumacher T.N., Hutt-Fletcher L.M., Wiertz E.J. Interference with T cell receptor-HLA-DR interactions by Epstein-Barr virus gp42 results in reduced T helper cell recognition. Proc. Natl Acad. Sci. U. S. A. 2003, 100:11583-11588.
26. Ressing M.E., van Leeuwen D., Verreck F.A., Keating S., Gomez R., Franken K.L., Ottenhoff T.H., Spriggs M., Schumacher T.N., Hutt-Fletcher L.M., Rowe M., Wiertz E.J. Epstein-Barr virus gp42 is posttranslationally modified to produce soluble gp42 that mediates HLA class II immune evasion. J. Virol. 2005, 79:841-852.
27. Rickinson A.B., Kieff E. Epstein-Barr virus. Fields' Virology 2007, 2656-2700. Lippincott Williams& Wilkins, Philadelphia. B.N. Fields, D.M.K., P.M. Howley (Eds.).
28. Shaw P.L., Kirschner A.N., Jardetzky T.S., Longnecker R. Characteristics of Epstein-Barr virus envelope protein gp42. Virus Genes 2010, 40:307-319.
29. Silva A.L., Omerovic J., Jardetzky T.S., Longnecker R. Mutational analyses of Epstein-Barr virus glycoprotein 42 reveal functional domains not involved in receptor binding but required for membrane fusion. J. Virol. 2004, 78:5946-5956.
30. Sloan V.S., Cameron P., Porter G., Gammon M., Amaya M., Mellins E., Zaller D.M. Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature 1995, 375:802-806.
31. Sorem J., Jardetzky T.S., Longnecker R. Cleavage and secretion of Epstein-Barr virus glycoprotein 42 promote membrane fusion with B lymphocytes. J. Virol. 2009, 83:6664-6672.
32. Spriggs M.K., Armitage R.J., Comeau M.R., Strockbine L., Farrah T., Macduff B., Ulrich D., Alderson M.R., Mullberg J., Cohen J.I. The extracellular domain of the Epstein-Barr virus BZLF2 protein binds the HLA-DR beta chain and inhibits antigen presentation. J. Virol. 1996, 70:5557-5563.
33. Takada K. Role of Epstein-Barr virus in Burkitt's lymphoma. Curr. Top. Microbiol. Immunol. 2001, 258:141-151.
34. Tanner J., Weis J., Fearon D., Whang Y., Kieff E. Epstein-Barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosis. Cell 1987, 50:203-213.
35. Thompson M.P., Kurzrock R. Epstein-Barr virus and cancer. Clin. Cancer Res. 2004, 10:803-821.
36. Wei W.I., Sham J.S. Nasopharyngeal carcinoma. Lancet 2005, 365:2041-2054.
37. Whitbeck J.C., Peng C., Lou H., Xu R., Willis S.H., Ponce de Leon M., Peng T., Nicola A.V., Montgomery R.I., Warner M.S., Soulika A.M., Spruce L.A., Moore W.T., Lambris J.D., Spear P.G., Cohen G.H., Eisenberg R.J. Glycoprotein D of herpes simplex virus (HSV) binds directly to HVEM, a member of the tumor necrosis factor receptor superfamily and a mediator of HSV entry. J. Virol. 1997, 71:6083-6093.
38. Yaswen L.R., Stephens E.B., Davenport L.C., Hutt-Fletcher L.M. Epstein-Barr virus glycoprotein gp85 associates with the BKRF2 gene product and is incompletely processed as a recombinant protein. Virology 1993, 195:387-396.